摘要
背景:个性化药物正在成为普遍的努力,在正确的时间为正确的患者提供正确的治疗。但是,它缺乏对非医疗因素的考虑,如患者的偏好和社会心理因素,这些都是不应该避免的。 目的和方法:本研究总结了炎症性肠病(IBD)患者在疾病不同阶段经历的心理社会困难,以确定评估心理社会危险因素和个性化治疗策略的方法。为了实现这一目标,量化文献与患者的观点相匹配,提供IBD患者经历的心理社会风险因素的广泛概述。 结果:定量结果为IBD的特定心理社会危险因素和心理社会干预结果不足提供了有力证据,但是缺乏个性化的研究,手段和干预措施,增加了研究结果与临床实践之间的距离。与此同时,定性研究结果显示出重要的意义,尽管定量研究揭示了掩盖的信息(例如身份恢复,争夺控制权,性关切),这可以作为进一步探索的出发点。 结论:本研究表明需要采取个体化治疗方法并提供心理治疗,同时考虑患者的经历和偏好。
关键词: 临床心理学,炎症性肠病,混合方法,个性化药物,心理相关因素,心理干预。
图形摘要
Current Drug Targets
Title:Personalizing Psychological Treatment Along the IBD Journey: From Diagnosis to Surgery
Volume: 19 Issue: 7
关键词: 临床心理学,炎症性肠病,混合方法,个性化药物,心理相关因素,心理干预。
摘要: Background: Personalized medicine is becoming a widespread effort to provide the right treatment to the right patient at the right time. However, it lacks of consideration for nonmedical factors, such as patient preferences and psychosocial factors, which should not be avoided.
Objective and Methods: The present study summarizes the psychosocial difficulties experienced by patients with inflammatory bowel disease (IBD) during different phases of the disease in order to identify methods to assess psychosocial risk factors and personalize treatment strategies. To reach this goal, the quantitative literature is matched with the patients' perspective, offering a broad overview of psychosocial risk factors that IBD patients experience.
Results: Quantitative results offer strong evidences for specific psychosocial risk factors in IBD and for weak results of psychosocial interventions, but show a lack of individually tailored researches, instruments and interventions, increasing the distance between the research findings and clinical practice. At the same time, qualitative findings show important, though veiled information uncovered by the quantitative research (e.g., identity recovery, fight for control, sexual concerns), which may be used as a starting point for further explorations.
Conclusion: The present study suggests a need to adopt individualized therapeutic approach and deliver psychological therapies while taking into account patients' experiences and preferences.
Export Options
About this article
Cite this article as:
Personalizing Psychological Treatment Along the IBD Journey: From Diagnosis to Surgery, Current Drug Targets 2018; 19 (7) . https://dx.doi.org/10.2174/1389450118666170502142939
DOI https://dx.doi.org/10.2174/1389450118666170502142939 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dimethyl Sulfoxide as an Excitatory Modulator and its Possible Role in Cancer Pain Management
Inflammation & Allergy - Drug Targets (Discontinued) The Quinolone Family: From Antibacterial to Anticancer Agents
Current Medicinal Chemistry - Anti-Cancer Agents SUBJECT INDEX TO VOLUME 4 Current Organic Chemistry
Current Organic Chemistry p35 Deficiency Accelerates HMGB-1-mediated Neuronal Death in the Early Stages of an Alzheimer's disease Mouse Model
Current Alzheimer Research Neurobiology of Alzheimer’s Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions
Current Alzheimer Research Brain local and regional neuroglial alterations in Alzheimer´s Disease: cell types, responses and implications.
Current Alzheimer Research Projecting Dynamic Trends for HIV/AIDS in a Highly Endemic Area of China: Estimation Models for Liangshan Prefecture, Sichuan Province
Current HIV Research UPLC-DAD Assisted Phytochemical Quantitation Reveals a Sex, Ploidy and Ecogeography Specificity in the Expression Levels of Selected Secondary Metabolites in Medicinal Tinospora cordifolia: Implications for Elites’ Identification Program
Current Topics in Medicinal Chemistry Drug Metabolism and Pharmacokinetics in Support of Drug Design
Current Pharmaceutical Design Recent Advances in 1,3,5-Triazine Derivatives as Antibacterial Agents
Mini-Reviews in Organic Chemistry Indoleamine 2,3-Dioxygenase in Immune Suppression and Cancer
Current Cancer Drug Targets Stress Response Regulation in Panic Disorder
Current Pharmaceutical Design Drug release from ordered mesoporous silicas
Current Pharmaceutical Design Impact of Ritonavir, Atazanavir and Their Combination on the CYP3A4 Induction by Efavirenz in Primary Human Hepatocytes
Drug Metabolism Letters Near-Infrared Dyes: Probe Development and Applications in Optical Molecular Imaging
Current Organic Synthesis Novel Pharmacological Targets for Cannabinoids
Current Neuropharmacology Preface [Hot Topic: Multifaceted Treatment of Schizophrenia (Executive Editor: J. Ananth)]
Current Pharmaceutical Design Development and Significance of the Frailty Concept in the Elderly: A Possible Modern View
CNS & Neurological Disorders - Drug Targets <i>Piper sarmentosum</i> Roxb. Attenuates Beta Amyloid (Aβ)-Induced Neurotoxicity <i>Via</i> the Inhibition of Amyloidogenesis and Tau Hyperphosphorylation in SH-SY5Y Cells
Current Alzheimer Research Characterization of Supraventricular Tachycardia in Infants: Clinical and Instrumental Diagnosis
Current Pharmaceutical Design